Is this your brand? Sign in to claim ownership.
Sign in to claim this brandMYCO MEDICAL SUPPLIES INC.
US
Last updated May 23, 2026
What MYCO MEDICAL SUPPLIES INC. makes
MYCO Medical Supplies Inc. manufactures single-use hypodermic and spinal needles, plain catgut and bioabsorbable polyester sutures (monofilament and multifilament), non-bioabsorbable nylon sutures, and invasive blood collection sets with non-fixed needles.
The company’s products are classified under FDA’s Class I and Class II categories and are listed in the FDA’s Unique Device Identifier (UDI) database. The manufacturer is based in the United States.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What types of medical devices does MYCO Medical Supplies Inc. manufacture?
MYCO Medical Supplies Inc. specializes in single-use medical devices, including hypodermic needles, spinal needles, sutures (such as plain catgut, bioabsorbable polyester in both monofilament and multifilament forms, and non-bioabsorbable nylon), and invasive blood collection sets with non-fixed needles. These products are designed for procedures like injections, suturing, and blood draws.
Where is MYCO Medical Supplies Inc. based?
MYCO Medical Supplies Inc. is headquartered in the United States. The company’s location is relevant for regulatory compliance and distribution, as it operates within the FDA’s jurisdiction.
Which regulatory registries or databases list MYCO Medical Supplies Inc.’s devices?
MYCO Medical Supplies Inc.’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. The UDI system helps track and identify medical devices for regulatory and safety purposes, ensuring transparency in the supply chain.
How are MYCO Medical Supplies Inc.’s devices classified under FDA regulations?
MYCO Medical Supplies Inc.’s devices fall under FDA’s Class I and Class II categories. Class I devices generally pose minimal risk and are subject to general controls, while Class II devices require additional regulations due to moderate risk. The classification depends on factors like the device’s purpose, duration of use, and potential harm if misused.
Why do some of MYCO Medical Supplies Inc.’s devices appear under multiple categories?
The company’s devices are categorized based on their specific functions, materials, and intended use. For example, sutures are classified differently depending on whether they are bioabsorbable or non-bioabsorbable, and needles are grouped by type (e.g., hypodermic vs. spinal). This classification helps regulators apply appropriate safety and performance standards tailored to each device’s risk level.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- US
- Address
- —
- Website
- —
- —
- —
- —
- Phone
- —
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- —
- DUNS Number
- 879187821
Catalogue (731)
Page 1 of 15| Device | Model / Reference | Registries | Class | Status |
|---|---|---|---|---|
| Reli® | SHN18G101-S1ML-LDS | FDA UDI | Class II | Active |
| Reli® | V340-M | FDA UDI | Class II | Active |
| Reli | PT556-P | FDA UDI | Class II | Active |
| Reli | GC636-P | FDA UDI | Class II | Active |
| Reli | P8695-P | FDA UDI | Class II | Active |
| Reli | N1663-P | FDA UDI | Class II | Active |
| Reli | INSY30G18751-S1ML | FDA UDI | Class II | Active |
| Wealy® RELI® | SS10ML22G151 | FDA UDI | Class II | Active |
| Reli® | GSIS21G-3 | FDA UDI | Class II | Active |
| Reli® | SHN21G151-S10ML | FDA UDI | Class II | Active |
| Reli | GP821-BRC | FDA UDI | Class II | Active |
| Reli® | GC203-M | FDA UDI | Class II | Active |
| Reli | SHN24G151 | FDA UDI | Class II | Active |
| Reli | SHN25G6251 | FDA UDI | Class II | Active |
| Wealy® RELI® | SS5ML23G101 | FDA UDI | Class II | Active |
| Reli | VU494-P | FDA UDI | Class II | Active |
| Reli | R-FSC1820B | FDA UDI | Class II | Active |
| Reli® | SHN23G101-S3ML-LDS | FDA UDI | Class II | Active |
| Reli® | ML333-M | FDA UDI | Class II | Active |
| Reli® | ML398-M | FDA UDI | Class II | Active |
| Reli® | HYP20G101-RW-S5ML | FDA UDI | Class II | Active |
| Reli | SHN27G051 | FDA UDI | Class II | Active |
| Reli® | P8683-M | FDA UDI | Class II | Active |
| Reli® | SBCN-R20G101T | FDA UDI | Class II | Active |
| Reli® | GP324-M | FDA UDI | Class II | Active |
| Reli® | V339-M | FDA UDI | Class II | Active |
| Reli® | SBCN-R22G114T | FDA UDI | Class II | Active |
| Reli® | SBCN-R21G101T | FDA UDI | Class II | Active |
| Reli® | N661-M | FDA UDI | Class II | Active |
| Reli | N661-P | FDA UDI | Class II | Active |
| Myco | 6001-3M | FDA UDI | Class I | Active |
| Reli | SHN30G051-S1ML-LDS | FDA UDI | Class II | Active |
| Reli | MS316-SI | FDA UDI | Class II | Active |
| Reli | BCN-R21G101 | FDA UDI | Class II | Active |
| Reli | SHN23G151 | FDA UDI | Class II | Active |
| Reli® | P1013-M | FDA UDI | Class II | Active |
| Reli® | GSBCS25G-7 | FDA UDI | Class II | Active |
| Reli | S10ML-BFN18G151 | FDA UDI | Class II | Active |
| Reli | BCN-R20G101 | FDA UDI | Class II | Active |
| Reli | N668-SI | FDA UDI | Class II | Active |
| Reli® | SHN21G101-S5ML | FDA UDI | Class II | Active |
| Reli® | GC621-M | FDA UDI | Class II | Active |
| Reli® | P8684-M | FDA UDI | Class II | Active |
| Reli® | GSBCS23G-7T | FDA UDI | Class II | Active |
| Reli | CHE20G701 | FDA UDI | Class II | Active |
| Myco | 6001-06 | FDA UDI | Class I | Active |
| Reli® | SHN20G201 | FDA UDI | Class II | Active |
| Reli | R-CLT1411 | FDA UDI | Class II | Active |
| Reli® | P8687-M | FDA UDI | Class II | Active |
| Reli | V463-SI | FDA UDI | Class II | Active |
Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.
FDA Recalls (2)
Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.
Myco Medical Supplies Inc. has two FDA recall records, both initiated as voluntary actions in 2013 and 2015, with both currently marked as terminated. The first, initiated on February 7, 2013, involved complaints of rubber coring from vial closures. The second, initiated on November 6, 2015, cited pouch labeling/printing errors and defective packaging that could affect sterility.
AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.
| Date | Recall No. | Class | Status | Reason |
|---|---|---|---|---|
| Nov 6, 2015 | Z-0444-2016 | — | terminated | Particulates: Complaints of rubber coring from the closure of injection vials. |
| Feb 7, 2013 | Z-0891-2013 | — | terminated | Pouch labeling/printing errors and defective packaging resulting in possible compromised sterility. |